ID   PDAC-X3
AC   CVCL_E4BW
RX   PubMed=39012569;
CC   Population: Chinese.
CC   Doubling time: 50 hours (PubMed=39012569).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): PubMed=39012569
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 15
ST   D12S391: 18
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 14
ST   D1S1656: 16
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 18,23
ST   Penta D: 11,12
ST   Penta E: 11,18
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=39012569; DOI=10.1007/s13577-024-01100-y;
RA   Chai, Chang-Peng
RA   Tang, Huan
RA   Miao, Xin
RA   Su, Yuan-Hui
RA   Li, Lu
RA   Yu, Cheng
RA   Yi, Jian-Feng
RA   Ye, Zhen-Zhen
RA   Miao, Long
RA   Zhang, Bo
RA   Wang, Zheng-Feng
RA   Luo, Wei
RA   Hu, Jin-Jing
RA   Zhang, Hui
RA   Zhou, Wen-Ce
RA   Xu, Hao
RT   "Establishment and characterization of the PDAC-X3 cell line: a novel
RT   Chinese-origin pancreatic ductal adenocarcinoma cell line.";
RL   Hum. Cell 37:1578-1592(2024).
//